KNOW TB: GET LITERATE

In-depth, public interest health journalism.

7th September 2013 | lightspeed

See this graphic larger.

TB treatment time cut by a third

By Amy Green, October 21, 2020

Posted in: Edition 10: Drug-resistant TB, Edition 7: TB, HIV/AIDS, Latest, TB

A new four-month treatment course for drug-sensitive tuberculosis (the most common form of TB by far) is as safe and effective as the current six-month treatment course that has been in use since the 1980s, according to findings from a large new study. Amy Green reports.

GeneXpert: An imperfect rollout

By lightspeed, September 4, 2013

Posted in: Edition 7: TB

[caption id="attachment_1504" align="alignnone" width="567"] Photo by Jose Cendon, courtesy of Médecins Sans Frontières[/caption] The GeneXpert tuberculosis (TB) test promises to revolutionise TB detection in South Africa. But will the rollout and implementation of this new system be good enough to fulfil its potential? “If a minister can do it, it…

2 Comments

Rifapentine: Trialled in SA but not available in SA

By Spotlight, September 8, 2013

Posted in: Edition 7: TB

A new tuberculosis treatment regimen has been shown to be safe and effective in a clinical trial conducted in southern Africa. However, the high cost and a lack of clear support from producers mean that access to the drug in the South African public sector is unlikely for years to…

KNOW TB: GET LITERATE

Related Posts

Leave a Reply Cancel reply